Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Eosinophilic Granulomatosis With Polyangiitis Treated With Mepolizumab at a Dose of 100 mg/month.

Moyano VA, Cuestas EI, Albiero JA, Ferreyra Dillon R, Pereyra BL, Perrone VE, Guendulain S, Lugones JI, Casas JP.

Arch Bronconeumol. 2020 Apr;56(4):253-254. doi: 10.1016/j.arbres.2019.09.019. Epub 2020 Feb 21. English, Spanish. No abstract available.

PMID:
32094026
2.

The QualiRede intervention: improving the performance of care continuum in HIV, congenital syphilis, and hepatitis C in health regions.

Nemes MIB, Castanheira ERL, Alves AM, Adania CSS, Loch AP, Monroe AA, Souza RA, Gianna MC, Caminada S, Farias NSO, Sousa POE, Domingues CSB, Silva MHD, Cervantes V, Yamashiro J, Caraciolo JMM, Silva FLD, Nemes Filho A, Jesus GL, Helena ETS, Albiero JFG, Lima MSS, Bellenzani R, Kehrig RT, Vale FCD, Nunes LO, Mendonça CS, Zarili TFT, Vilela MC, Dantas JCO, Paula I, Tayra Â, Coelho DM, Santos GPD, Quevedo DC, Silva MAD, Silva IBD, Nasser MA, Andrade MC, Santos MA, Mercuri J, Trindade KV, Neves MATD, Toledo RVA, Almeida MCR, Lima IN.

Rev Bras Epidemiol. 2019 Sep 26;22Suppl 1(Suppl 1):e190010. doi: 10.1590/1980-549720190010.supl.1. eCollection 2019. English, Portuguese.

3.

Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant Acinetobacter baumannii Using Checkerboard Information.

Menegucci TC, Fedrigo NH, Lodi FG, Albiero J, Nishiyama SAB, Mazucheli J, Carrara-Marroni FE, Voelkner NMF, Gong H, Sy SKB, Tognim MCB.

Microb Drug Resist. 2019 Nov;25(9):1266-1274. doi: 10.1089/mdr.2018.0283. Epub 2019 Jun 19.

PMID:
31216222
4.

Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.

Albiero J, Mazucheli J, Barros JPDR, Szczerepa MMDA, Nishiyama SAB, Carrara-Marroni FE, Sy S, Fidler M, Sy SKB, Tognim MCB.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00126-19. doi: 10.1128/AAC.00126-19. Print 2019 Jun.

5.

Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.

Fedrigo NH, Mazucheli J, Albiero J, Shinohara DR, Lodi FG, Machado ACDS, Sy SKB, Tognim MCB.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02498-16. doi: 10.1128/AAC.02498-16. Print 2017 Aug.

6.

Outbreak of Klebsiella pneumoniae carbapenemase-producing K pneumoniae: A systematic review.

Campos AC, Albiero J, Ecker AB, Kuroda CM, Meirelles LE, Polato A, Tognim MC, Wingeter MA, Teixeira JJ.

Am J Infect Control. 2016 Nov 1;44(11):1374-1380. doi: 10.1016/j.ajic.2016.03.022. Epub 2016 May 5. Review.

PMID:
27156198
7.

[Medium vessel vasculitis in Systemic Lupus Erythematosus].

Maldonado A, Blanzari JN, Asbert P, Albiero JA, Gobbi C, Albiero E, Alba P.

Rev Fac Cien Med Univ Nac Cordoba. 2016;73(1):50-2. Spanish. No abstract available.

PMID:
27419897
8.

Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae.

Albiero J, Sy SK, Mazucheli J, Caparroz-Assef SM, Costa BB, Alves JL, Gales AC, Tognim MC.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4128-39. doi: 10.1128/AAC.03099-15. Print 2016 Jul.

9.

Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections.

Menegucci TC, Albiero J, Migliorini LB, Alves JL, Viana GF, Mazucheli J, Carrara-Marroni FE, Cardoso CL, Tognim MC.

Int J Antimicrob Agents. 2016 May;47(5):380-5. doi: 10.1016/j.ijantimicag.2016.02.007.

PMID:
27068675

Supplemental Content

Loading ...
Support Center